• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压、肥胖与肾脏之间关系的新方面。

New aspects of the relationship among hypertension, obesity, and the kidneys.

作者信息

Sachse Anja, Wolf Gunter

机构信息

Klinik für Innere Medizin III, University of Jena, Erlanger Allee 101, D-07347 Jena, Germany.

出版信息

Curr Hypertens Rep. 2008 Apr;10(2):138-42. doi: 10.1007/s11906-008-0026-x.

DOI:10.1007/s11906-008-0026-x
PMID:18474181
Abstract

Recent studies have highlighted the association between obesity and chronic renal disease. Overweight has been shown to be a survival advantage in patients on maintenance hemodialysis therapy. However, in patients with preterminal renal failure, obesity may contribute to the progression of renal disease. Data collected from the Prevention of Renal and Vascular End-stage Disease study suggest that changes in weight directly influence albuminuria, hinting that albumin excretion could be used in the general population as a surrogate marker for risk of developing chronic kidney disease. The causal pathways linking excess weight to chronic kidney disease and hypertension are briefly reviewed in this article, and therapeutic approaches to combat this growing health problem are highlighted.

摘要

近期研究突显了肥胖与慢性肾病之间的关联。超重已被证明对维持性血液透析治疗的患者具有生存优势。然而,在终末期肾衰竭前期患者中,肥胖可能会促使肾病进展。从预防肾和血管终末期疾病研究收集的数据表明,体重变化直接影响蛋白尿,这暗示在普通人群中,白蛋白排泄可作为慢性肾病发病风险的替代标志物。本文简要回顾了将超重与慢性肾病及高血压联系起来的因果途径,并着重介绍了应对这一日益严重的健康问题的治疗方法。

相似文献

1
New aspects of the relationship among hypertension, obesity, and the kidneys.高血压、肥胖与肾脏之间关系的新方面。
Curr Hypertens Rep. 2008 Apr;10(2):138-42. doi: 10.1007/s11906-008-0026-x.
2
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.高血压患者的亚临床肾损伤:打开一扇观察心血管系统的肾脏之窗。聚焦微量白蛋白尿。
Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85.
3
Is obesity a major cause of chronic kidney disease?肥胖是慢性肾病的主要病因吗?
Adv Ren Replace Ther. 2004 Jan;11(1):41-54. doi: 10.1053/j.arrt.2003.10.007.
4
Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population.代谢综合征而非肥胖指标是普通人群中与年龄相关的肾小球滤过率加速下降的危险因素。
Kidney Int. 2018 May;93(5):1183-1190. doi: 10.1016/j.kint.2017.11.012. Epub 2018 Feb 1.
5
Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench.晚期肾病中的肥胖悖论:从床边到实验台。
Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):168-181. doi: 10.1016/j.pcad.2018.07.001. Epub 2018 Jul 4.
6
Overweight, obesity, hypertension and albuminuria in Polish adolescents--results of the Sopkard 15 study.波兰青少年超重、肥胖、高血压和白蛋白尿——Sopkard 15 研究结果。
Nephrol Dial Transplant. 2013 Nov;28 Suppl 4:iv204-11. doi: 10.1093/ndt/gft328. Epub 2013 Sep 24.
7
Combined renal effects of overweight and hypertension.
Hypertension. 1995 Oct;26(4):610-5. doi: 10.1161/01.hyp.26.4.610.
8
Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'.假设:肥胖和胰岛素抵抗综合征在归因于高血压并被称为“高血压性肾硬化”的终末期肾衰竭中起主要作用。
J Hypertens. 2004 Jun;22(6):1051-5. doi: 10.1097/00004872-200406000-00001.
9
The obesity-survival paradox in hemodialysis patients: why do overweight hemodialysis patients live longer?血液透析患者中的肥胖-生存悖论:为何超重的血液透析患者寿命更长?
Nutr Clin Pract. 2007 Feb;22(1):11-5. doi: 10.1177/011542650702200111.
10
[Effects of the overlapping between an experimental model of neuroendocrine obesity with arterial hypertension under blood pressure, body weight and metabolic and renal parameters in rats].
J Bras Nefrol. 2011 Jul-Sep;33(3):338-44. doi: 10.1590/s0101-28002011000300010.

引用本文的文献

1
Application value of weight-adjusted waist circumference index and cardiometabolic index in hypertensive patients with albuminuria: results from the National Health and Nutrition Examination Survey 2005-2020.体重校正腰围指数和心脏代谢指数在高血压合并蛋白尿患者中的应用价值:2005 - 2020年美国国家健康与营养检查调查结果
Ren Fail. 2025 Dec;47(1):2506813. doi: 10.1080/0886022X.2025.2506813. Epub 2025 May 28.
2
Adipose Stromal Cell Expansion and Exhaustion: Mechanisms and Consequences.脂肪基质细胞的扩增和耗竭:机制与后果。
Cells. 2020 Apr 2;9(4):863. doi: 10.3390/cells9040863.
3
The impact of blood pressure on kidney function in the elderly: a cross-sectional study.

本文引用的文献

1
Low urine pH: a novel feature of the metabolic syndrome.低尿pH值:代谢综合征的一个新特征。
Clin J Am Soc Nephrol. 2007 Sep;2(5):883-8. doi: 10.2215/CJN.00670207. Epub 2007 Aug 16.
2
Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population.没有糖尿病的代谢综合征患者有患慢性肾病的风险吗?基于大规模队列筛查人群数据的证据。
Clin J Am Soc Nephrol. 2007 Sep;2(5):976-83. doi: 10.2215/CJN.01020207. Epub 2007 Aug 8.
3
Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.
老年人血压对肾功能的影响:一项横断面研究。
Kidney Blood Press Res. 2013;38(2-3):205-16. doi: 10.1159/000355769. Epub 2014 Apr 9.
4
Alternative origins of stroma in normal organs and disease.正常器官和疾病中基质的其他来源。
Stem Cell Res. 2012 Mar;8(2):312-23. doi: 10.1016/j.scr.2011.11.005. Epub 2011 Dec 8.
中度慢性肾脏病患者体型与代谢综合征及死亡率的关联
Clin J Am Soc Nephrol. 2007 Sep;2(5):992-8. doi: 10.2215/CJN.04221206. Epub 2007 Aug 16.
4
Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.肥胖与肥胖引发的代谢综合征:与慢性肾脏病的机制联系
Clin J Am Soc Nephrol. 2007 May;2(3):550-62. doi: 10.2215/CJN.04071206. Epub 2007 Mar 14.
5
Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis.尚未接受透析的慢性肾脏病男性患者中,体重指数与死亡率之间存在矛盾的关联。
Am J Kidney Dis. 2007 May;49(5):581-91. doi: 10.1053/j.ajkd.2007.02.277.
6
Impact of weight change on albuminuria in the general population.体重变化对普通人群蛋白尿的影响。
Nephrol Dial Transplant. 2007 Jun;22(6):1619-27. doi: 10.1093/ndt/gfm091. Epub 2007 Mar 14.
7
Glomerular hyperfiltration: a new marker of metabolic risk.肾小球高滤过:代谢风险的新标志物。
Kidney Int. 2007 Apr;71(8):816-21. doi: 10.1038/sj.ki.5002160. Epub 2007 Feb 28.
8
Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004.1999 - 2004年美国慢性肾脏病患病率及相关危险因素
MMWR Morb Mortal Wkly Rep. 2007 Mar 2;56(8):161-5.
9
Metabolic actions of angiotensin receptor antagonists: PPAR-gamma agonist actions or a class effect?血管紧张素受体拮抗剂的代谢作用:过氧化物酶体增殖物激活受体γ激动剂作用还是类效应?
Curr Opin Pharmacol. 2007 Apr;7(2):140-5. doi: 10.1016/j.coph.2006.11.008. Epub 2007 Feb 15.
10
Excess weight as a risk factor for kidney failure.超重作为肾衰竭的一个风险因素。
Curr Opin Nephrol Hypertens. 2007 Mar;16(2):71-6. doi: 10.1097/MNH.0b013e32802ef4b6.